Home/Smart Money/REGENERON PHARMACEUTICALS, INC.
§ 13F · FUND PROFILE

REGENERON PHARMACEUTICALS, INC..

Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $1485.0T (13F)Positions · 4Turnover · · Q4Filed · Feb 6, 2026
CONCENTRATION
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
No prior quarter data
3YR HIT RATE
Top-5 overlap
§ 01 · TOP HOLDINGS

The book · Q4 2025

FILED FEB 6, 2026
#TickerNameShares$ value% portΔ Q4
1NTLAIntellia Therapeutics, Inc.3.70M$33.3T98.5%±0%
2TORCEURAdicet Bio, Inc.61K$509.5B1.5%−94%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE REGENERON SIGNAL

AC read

REGENERON PHARMACEUTICALS, INC. is a Other fund managing $1485002.7 trillion in assets. The fund runs a focused portfolio of just 4 positions.

Read the full dossier →
§ 04 · FILING HISTORY

Q-by-Q deltas

1 FILINGS
Q4 2025
Steady book
+0 buys · 0 exits · 0 changed
Q3 2025
Steady book
+0 buys · 0 exits · 0 changed
Q2 2025
Steady book
+0 buys · 0 exits · 0 changed
Q1 2025
Steady book
+0 buys · 0 exits · 0 changed